515 related articles for article (PubMed ID: 25285793)
1. Clinical effectiveness and cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men: risk calculators for real-world decision-making.
Chen A; Dowdy DW
PLoS One; 2014; 9(10):e108742. PubMed ID: 25285793
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016.
Ong KJ; Desai S; Field N; Desai M; Nardone A; van Hoek AJ; Gill ON
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067902
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: a mathematical modelling study.
Choi H; Suh J; Lee W; Kim JH; Kim JH; Seong H; Ahn JY; Jeong SJ; Ku NS; Park YS; Yeom JS; Kim C; Kwon HD; Smith DM; Lee J; Choi JY
Sci Rep; 2020 Sep; 10(1):14609. PubMed ID: 32884082
[TBL] [Abstract][Full Text] [Related]
4. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.
Zhao R; Fairley CK; Cook AR; Phanuphak N; He S; Tieosapjaroen W; Chow EPF; Phillips TR; Jin Tan RK; Wei Y; Shen M; Zhuang G; Ong JJ; Zhang L
Lancet Glob Health; 2024 Feb; 12(2):e243-e256. PubMed ID: 38245115
[TBL] [Abstract][Full Text] [Related]
5. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
[TBL] [Abstract][Full Text] [Related]
6. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and cost-effectiveness of early antiretroviral therapy and partners' pre-exposure prophylaxis among men who have sex with men in Shenyang, China: a prospective cohort and costing study.
Hu QH; Meyers K; Xu JJ; Chu ZX; Zhang J; Ding HB; Han XX; Jiang YJ; Geng WQ; Shang H
BMC Infect Dis; 2019 Jul; 19(1):663. PubMed ID: 31345169
[TBL] [Abstract][Full Text] [Related]
8. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China.
Li J; Peng L; Gilmour S; Gu J; Ruan Y; Zou H; Hao C; Hao Y; Lau JT
BMC Infect Dis; 2018 Nov; 18(1):600. PubMed ID: 30486800
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.
Juusola JL; Brandeau ML; Owens DK; Bendavid E
Ann Intern Med; 2012 Apr; 156(8):541-50. PubMed ID: 22508731
[TBL] [Abstract][Full Text] [Related]
10. Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men.
McKenney J; Chen A; Hoover KW; Kelly J; Dowdy D; Sharifi P; Sullivan PS; Rosenberg ES
PLoS One; 2017; 12(6):e0178170. PubMed ID: 28570572
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
Cambiano V; Miners A; Dunn D; McCormack S; Ong KJ; Gill ON; Nardone A; Desai M; Field N; Hart G; Delpech V; Cairns G; Rodger A; Phillips AN
Lancet Infect Dis; 2018 Jan; 18(1):85-94. PubMed ID: 29054789
[TBL] [Abstract][Full Text] [Related]
12. Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men.
Ross EL; Cinti SK; Hutton DW
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):e61-7. PubMed ID: 26977749
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of HIV pre-exposure prophylaxis in Japan.
Mizushima D; Nagai Y; Mezzio D; Harada K; Piao Y; Barnieh L; El Moustaid F; Cawson M; Taniguchi T
J Med Econ; 2023; 26(1):886-893. PubMed ID: 37421417
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost effectiveness of oral pre-exposure prophylaxis in a portfolio of prevention programs for injection drug users in mixed HIV epidemics.
Alistar SS; Owens DK; Brandeau ML
PLoS One; 2014; 9(1):e86584. PubMed ID: 24489747
[TBL] [Abstract][Full Text] [Related]
15. Competing biomedical HIV prevention strategies: potential cost-effectiveness of HIV vaccines and PrEP in Seattle, WA.
Adamson B; Garrison L; Barnabas RV; Carlson JJ; Kublin J; Dimitrov D
J Int AIDS Soc; 2019 Aug; 22(8):e25373. PubMed ID: 31402591
[TBL] [Abstract][Full Text] [Related]
16. Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.
Amick AK; Eskibozkurt GE; Hosek SG; Flanagan CF; Landovitz RJ; Jin EY; Wilson CM; Freedberg KA; Weinstein MC; Kazemian P; Paltiel AD; Ciaranello AL; Neilan AM
Clin Infect Dis; 2024 Feb; 78(2):402-410. PubMed ID: 37823865
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Pre-Exposure Prophylaxis Among Adolescent Sexual Minority Males.
Wang LY; Hamilton DT; Rosenberg ES; Aslam MV; Sullivan PS; Katz DA; Dunville RL; Barrios LC; Goodreau SM
J Adolesc Health; 2020 Jan; 66(1):100-106. PubMed ID: 31757626
[TBL] [Abstract][Full Text] [Related]
18. Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel.
Ginsberg GM; Chemtob D
BMC Public Health; 2020 Feb; 20(1):271. PubMed ID: 32103750
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of a Statewide Pre-Exposure Prophylaxis Program for Gay, Bisexual, and Other Men Who Have Sex with Men.
Goedel WC; Chan PA; King MRF; Prosperi MCF; Marshall BDL; Galárraga O
R I Med J (2013); 2019 Nov; 102(9):36-39. PubMed ID: 31675786
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study.
Nichols BE; Boucher CAB; van der Valk M; Rijnders BJA; van de Vijver DAMC
Lancet Infect Dis; 2016 Dec; 16(12):1423-1429. PubMed ID: 27665989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
